Skip to main content

Table 2 Prevalence of COPD in patients hospitalized with COVID-19

From: Asthma and COPD as co-morbidities in patients hospitalised with Covid-19 disease: a global systematic review and meta-analysis

Subregion

Number of studies

Random model pooled prevalence (expressed as percentage)

95% Confidence Intervals

P for difference from reference subregion

North America

10

10.4

7.3–14.5

Reference region

North Europe

6

7.0

5.6–8.7

0.0145 *

South Europe

10

7.6

5.9–9.6

0.0774

Western Europe

4

9.9

7.4–13.0

0.8463

East Asia

6

1.4

0.9–2.1

0.0001*

Central America

2

6.5

2.6–15.4

0.1256

  1. *Signifies statistically significant, two tailed at the 5% level